Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
(16 July 2015)
The risk of hypoglycaemia with GLP-1 medications is generally low unless they are used in combination with insulin or sulfonylureas
The muscle loss associated with GLP-1 drug use is particularly concerning in older adults (50+) whose muscle mass and bone density is typically declining due to aging anyway, increasing the risk of fractures and falls, even fatal ones
Competing interests DG received honoraria for speaking at meetings from Novartis, Sanofi, Eli Lilly and Company, AstraZeneca, and Novo Nordisk
US$ 29.51
US$ 21.18
US$ 25.96
US$ 20.67
